Modulation of immune response and T-cell regulation by donor adipose-derived stem cells in a rodent hind-limb allotransplant model

Plastic and Reconstructive Surgery

Volumn 128, Issue 6, 2011, Pages

  Kuo, Yur Ren ^a,b,c   Chen, Chien Chang ^a,b,c   Goto, Shigeru ^a,b,c   Lee, I Te ^a,b,c   Huang, Chong Wei ^a,b,c   Tsai, Chia Chun ^a,b,c   Wang, Chun Ting ^a,b,c   Chen, Chao Long ^a,b,c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b Department of Surgery   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY;

ADIPOSE TISSUE; ALLOTRANSPLANTATION; ANIMAL; ARTICLE; BROWN NORWAY RAT; CYTOLOGY; DONOR; GRAFT REJECTION; GRAFT SURVIVAL; HINDLIMB; HISTOCOMPATIBILITY; IMMUNOLOGY; IMMUNOMODULATION; LEWIS RAT; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; PATHOLOGY; RAT; REGULATORY T LYMPHOCYTE; STEM CELL; TRANSPLANTATION;

ADIPOSE TISSUE; ANIMALS; ANTILYMPHOCYTE SERUM; CYCLOSPORINE; CYTOKINES; GRAFT REJECTION; GRAFT SURVIVAL; HINDLIMB; IMMUNOMODULATION; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MALE; RATS; RATS, INBRED BN; RATS, INBRED LEW; STEM CELLS; T-LYMPHOCYTES, REGULATORY; TISSUE DONORS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 81855177169     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e318230c60b     Document Type: Article

References (23)

1. Lee WP. Composite tissue transplantation: More science and patience needed. Plast Reconstr Surg. 2001;107:1066-1070.
2. Dubernard JM, Devauchelle B. Face transplantation. Lancet 2008;372:603-604.
3. Jones JW, Gruber SA, Barker JH, Breidenbach WC. Successful hand transplantation: One-year follow-up. Louisville Hand Transplant Team. N Engl J Med. 2000;343:468-473.
4. Dubernard JM, LengeléB, Morelon E, et al. Outcomes 18 months after the first human partial face transplantation. N Engl J Med. 2007;357:2451-2460.
5. Lee WP, Yaremchuk MJ, Pan YC, Randolph MA, Tan CM, Weiland AJ. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg. 1991;87:401-411.
6. Madani H, Hettiaratchy S, Clarke A, Butler PE. Immunosuppression in an emerging field of plastic reconstructive surgery: Composite tissue allotransplantation. J Plast Reconstr Aesthet Surg. 2008;61:245-249.
7. Mathes DW, Randolph MA, Lee WP. Strategies for tolerance induction to composite tissue allografts. Microsurgery 2000; 20:448-452.
8. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143-147.
9. Yagi H, Soto-Gutierrez A, Parekkadan B, et al. Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant. 2010;19:667-679.
10. English K, Ryan JM, Tobin L, Murphy MJ, Barry FP, Mahon BP. Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+regulatory T cells. Clin Exp Immunol. 2009; 156:149-160.
11. Krampera M, Glennie S, Dyson J, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003;101:3722-3729.
12. Parekkadan B, Tilles AW, Yarmush ML. Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. Stem Cells 2008; 26:1913-1919.
13. Kuo YR, Goto S, Shih HS, et al. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model. Transplantation 2009;87:1769-1777.
14. Kuo YR, Chen CC, Shih HS, et al. Prolongation of composite tissue allotransplant survival by treatment with bone marrow mesenchymal stem cells is correlated with T-cell regulation in a swine hind-limb model. Plast Reconstr Surg. 2011;127:569-579.
15. Izadpanah R, Trygg C, Patel B, et al. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem. 2006;99:1285-1297.
16. Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C. Adiposederived stem cells: Isolation, expansion and differentiation. Methods 2008;45:115-120.
17. Kuo YR, Huang CW, Goto S, et al. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation. J Surg Res. 2009;153:317-325.
18. Cendales LC, Kanitakis J, Schneeberger S, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant. 2008;8:1396-1400.
19. Ye Z, Wang Y, Xie HY, Zheng SS. Immunosuppressive effects of rat mesenchymal stem cells: Involvement of CD4+CD25+ regulatory T cells. Hepatobiliary Pancreat Dis Int. 2008;7:608-614.
20. Razmkhah M, Jaberipour M, Erfani N, Habibagahi M, Talei AR, Ghaderi A. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-beta1 and upregulate expression of regulatory molecules on T cells: Do they protect breast cancer cells from the immune response? Cell Immunol. 2011;266:116-122.
21. Gonzalez-Rey E, Gonzalez MA, Varela N, et al. Human adipose- derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis. 2010;69:241-248.
22. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105: 1815-1822.
23. Meisel R, Zibert A, Laryea M, Gobel U, Däubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic Tcell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004;103:4619-4621.